Michael Mega MD PhD
Providence Brain Institute
Criteria for Assessing Cognitive Impairment

3:30 PM - 5:30 PM

Thursday, June 17th 

Location
Regency Park Assisted Living and Memory Care
8300 SW Barnes Rd
Portland, OR

Sponsored by

NW Senior Resources - Placements & Referrals,
Providence Brain Institute,
Regency Park Assisted Living & Memory Care,

Registration Fees

$15 OGA Regular/Professional Members
$  5 OGA Student or Senior Members
$25 Non-Members

CLICK HERE for downloadable PDF 

Michael Mega, M.D., Ph.D., Is the director of the Cognitive Assessment Clinic in the Providence Brain Institute. Dr. Mega has done extensive research in the area of neuroimaging, mapping brain structure and function as it relates to Alzheimer’s disease and dementia. He received his medical degree from George Washington University in 1988 and completed his neurology residency at Boston University and a research fellowship in neurobehavior at University of California Los Angeles (UCLA) School of Medicine, as well as a PhD in neuroscience from UCLA with emphasis in brain mapping. Upon finishing his studies at UCLA, Dr. Mega held many posts at the university – from 1999 to 2002, he served as the director of the Imaging Sub-core Alzheimer’s Disease Research Center. Concurrently, he was the director of the Memory Disorders and Alzheimer’s disease Clinic, as well as an assistant professor in neurology.

Specific goals for this presentation:
1) Understand the diagnostic criteria for Mild Cognitive Impairment (MCI) and Alzheimer’s disease (AD).
2) Understand the difference in the memory loss of normal aging and that of early AD.
3) Understand the rationale for using selective amyloid lower agents (SALAS) in patients with MCI and AD.